123 related articles for article (PubMed ID: 6102812)
1. [Labetalol (Trandate). an antihypertensive agent with both alpha and beta receptor blockading effects].
Rasmussen S; Andreasen PB
Ugeskr Laeger; 1980 Mar; 142(13):839-41. PubMed ID: 6102812
[No Abstract] [Full Text] [Related]
2. [Hypertensive emergencies: clinical evaluation of the use of a new drug: labetalol hydrochloride].
Rossano P; Saffiotti O; Mayer MC; Blasich M; Rossano G; Bellotti P
Minerva Cardioangiol; 1980 May; 28(5):309-14. PubMed ID: 6111048
[No Abstract] [Full Text] [Related]
3. Labetalol, a new alpha- and beta-adrenoreceptor blocking agent, in hypertension.
Hansson L; Hänel B
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):763-4. PubMed ID: 10952
[TBL] [Abstract][Full Text] [Related]
4. [Combined alpha and beta adrenergic receptor blockade in the treatment of renal hypertension].
Stummvoll HK
Wien Med Wochenschr Suppl; 1981; 69():14-6. PubMed ID: 6123200
[No Abstract] [Full Text] [Related]
5. Labetalol in hypertension.
Lancet; 1977 May; 1(8022):1147-8. PubMed ID: 68239
[No Abstract] [Full Text] [Related]
6. Giant, dopamine secreting thoracoabdominal neuroblastoma in a 2-year-old: rapid preoperative blockade with labetalol.
Pappas L; Shamberger RC; Seefelder C
J Pediatr Hematol Oncol; 2010 Mar; 32(2):163-6. PubMed ID: 20147848
[TBL] [Abstract][Full Text] [Related]
7. Labetalol: an alpha- and beta-adrenergic receptor blocker.
Pepper GA
Nurse Pract; 1985 Jul; 10(7):39-40, 43, 48. PubMed ID: 3855235
[No Abstract] [Full Text] [Related]
8. Labetalol, an alpha- and beta-adrenergic blocking drug in the treatment of hypertension.
Rosei EA; Fraser R; Morton JJ; Brown JJ; Lever AF; Robertson JI; Trust PM
Am Heart J; 1977 Jan; 93(1):124-5. PubMed ID: 12654
[No Abstract] [Full Text] [Related]
9. Labetolol--combined alpha and beta blockade for hypertension.
Raftery EB
Scott Med J; 1978 Oct; 23(4):279-80. PubMed ID: 31683
[No Abstract] [Full Text] [Related]
10. [Therapeutic effect of trandat, an alpha- and beta-adrenergic receptor blockader, and its effect on central, regional and intracardiac hemodynamics].
Erina EV; Charyev KhE; Beliakova EV; Tverskaia LV; Kukharchuk VV
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1982; 5(1):68-74. PubMed ID: 6124260
[TBL] [Abstract][Full Text] [Related]
11. [Protective effect of alpha beta-blockers on hypertensive target-organ damage].
Kai H; Imaizumi T
Nihon Rinsho; 2004 Mar; 62 Suppl 3():587-90. PubMed ID: 15171441
[No Abstract] [Full Text] [Related]
12. Labetalol for hypertension.
Med Lett Drugs Ther; 1984 Sep; 26(670):83-5. PubMed ID: 6147747
[No Abstract] [Full Text] [Related]
13. Combined alpha- and beta-adrenergic blockade in the treatment of hypertension: myth or reality? Workshop held in Corsendonck (Belgium) on February 28, 1981.
J Cardiovasc Pharmacol; 1981; 3 Suppl 1():S1-74. PubMed ID: 6169955
[No Abstract] [Full Text] [Related]
14. [The new Russian preparation proxodolol in the treatment of arterial hypertension].
Ol'binskaia LI; Morozova TE
Eksp Klin Farmakol; 1994; 57(3):42-5. PubMed ID: 7914119
[TBL] [Abstract][Full Text] [Related]
15. Labetalol therapy in patients with systemic hypertension and angina pectoris: effects of combined alpha and beta adrenoceptor blockade.
Frishman WH; Strom JA; Kirschner M; Poland M; Klein N; Halprin S; LeJemtel TH; Kram M; Sonnenblick EH
Am J Cardiol; 1981 Nov; 48(5):917-28. PubMed ID: 6118060
[No Abstract] [Full Text] [Related]
16. Closing remarks: current status of labetalol.
Dollery CT
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):823-4. PubMed ID: 10954
[No Abstract] [Full Text] [Related]
17. Labetalol (AH5158), a competitive alpha- and beta-receptor blocking drug, in the management of hypertension.
Rosei EA; Brown JJ; Fraser R; Lever AF; Morton JJ; Robertson JI; Trust PM
Aust N Z J Med; 1976 Aug; 6(3 Suppl):83-8. PubMed ID: 14627
[TBL] [Abstract][Full Text] [Related]
18. Labetalol: an alpha- and beta-adrenoceptor blocking drug.
Michelson EL; Frishman WH
Ann Intern Med; 1983 Oct; 99(4):553-5. PubMed ID: 6137987
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of hypertension by labetalol (author's transl)].
Sternon J; Melot C; Contu E
Rev Med Brux; 1980 Nov; 1(9):615-21. PubMed ID: 7455430
[No Abstract] [Full Text] [Related]
20. Do hybrid drugs offer an additional benefit over pure alpha 1-blockade for hypertensive patients?
Doyle AE
J Hypertens Suppl; 1988 Dec; 6(2):S51-3. PubMed ID: 2906701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
